image
Healthcare - Biotechnology - NASDAQ - NL
$ 3.82
-3.29 %
$ 394 M
Market Cap
-12.32
P/E
BALANCE SHEET
138 M ASSETS
-19.45%
96.5 M LIABILITIES
-9.15%
41.4 M EQUITY
-36.81%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition ProQR Therapeutics N.V.
image
Current Assets 121 M
Cash & Short-Term Investments 119 M
Receivables 1.27 M
Other Current Assets 893 K
Non-Current Assets 16.9 M
Long-Term Investments 0
PP&E 16.9 M
Other Non-Current Assets 0
Current Liabilities 34.2 M
Accounts Payable 1.54 M
Short-Term Debt 1.61 M
Other Current Liabilities 31.1 M
Non-Current Liabilities 62.3 M
Long-Term Debt 18.1 M
Other Non-Current Liabilities 44.2 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 118.9 94.8 187.5 75.8 112.0 105.6 48.1 59.2 94.9 112.7 4.1 0.2
Short Term Investments 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 1.3 57.2 0 0.4 0 1.2 0 1.6 1.5 0.4 0.1 47 K
Inventory 0 6.86 K 0.3 0.4 0.3 0.9 73 K 1.2 0.5 0.3 0 0
Other Current Assets 0.8 2.4 3.1 (0.8) 1.5 (2.1) 2.0 1.2 1.4 (0.8) 2 K 3 K
Total Current Assets 121.1 154.5 191.5 80.0 114.7 108.4 50.6 62.0 97.8 113.9 4.3 0.3
PP&E 16.9 16.2 17.5 18.6 2.4 1.9 2.5 3.4 2.2 1.2 0.2 0
Intangible Assets 0 0 0 0 0 0 39 K 90 K 0.1 0.2 39 K 39 K
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0.6 0.6 0.1 0.4 0 0 0 0 0 0 0
Other Long Term Assets 0 0 0 0 0 0 0 0 0 0 0 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 138.0 171.3 209.6 98.7 117.5 110.2 53.1 65.5 100.1 115.2 4.5 0.3
LIABILITIES
Accounts Payable 1.5 0.4 0.2 0.2 0.4 0.1 0.5 0.3 0.9 1.2 0.7 95 K
Short Term Debt 1.6 3.9 6.3 2.4 0.9 0 2.0 0 15 K 34 K 2.5 0
Other Current Liabilities 8.8 10.1 14.8 7.0 8.8 7.5 4.6 6.1 4.2 1.4 0.3 45 K
Total Current Liabilities 34.2 21.1 27.6 10.3 11.0 8.2 8.5 6.7 5.5 3.0 3.6 0.1
Long Term Debt 18.1 18.1 54.1 31.9 12.7 9.4 5.3 5.7 4.8 2.8 1.0 96 K
Deferred Tax Income 0 0 (65.4) 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0 0 0 0 0 0
Total Liabilities 96.5 106.2 96.3 42.2 23.7 17.5 13.8 12.4 10.3 5.8 4.6 0.2
EQUITY
Common Stock 3.4 3.4 3.0 2.2 2.2 1.7 1.5 0.9 0.9 0.9 59 K 33 K
Retained Earnings (400.9) (380.7) (317.8) (257.7) (211.7) (155.4) (119.4) (75.7) (36.6) (15.8) (3.7) (0.4)
Other Accumulative Comprehensive Income/Loss 26.0 30.3 30.3 (0.2) 0.2 0.1 0.1 15 K 1 K 0.7 41 K 0
Total Equity 41.4 65.1 113.2 56.5 93.8 92.7 39.3 53.1 89.8 109.4 89 K 99 K
Total Liabilities and Equity 138.0 171.3 209.6 98.7 117.5 110.2 53.1 65.5 100.1 115.2 4.5 0.3
SHARES OUTSTANDING
Common Shares Outstanding 81.0 71.6 64.2 50.1 41.0 34.1 25.4 23.3 23.3 11.1 22.2